Aurobindo Historical Cash Flow
| AUROPHARMA | 1,119 9.70 0.86% |
Analysis of Aurobindo Pharma cash flow over time is an excellent tool to project Aurobindo Pharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 20.5 B or Begin Period Cash Flow of 35.5 B as it is a great indicator of Aurobindo Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aurobindo Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aurobindo Pharma is a good buy for the upcoming year.
Aurobindo |
About Aurobindo Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aurobindo balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aurobindo's non-liquid assets can be easily converted into cash.
Aurobindo Pharma Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Aurobindo Pharma to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Aurobindo Pharma operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Aurobindo Pharma financial statement analysis. It represents the amount of money remaining after all of Aurobindo Pharma Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Aurobindo Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aurobindo Pharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurobindo Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Aurobindo Pharma's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 20.5 B, whereas Sale Purchase Of Stock is projected to grow to (8.8 B).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 27.2B | 35.6B | 19.7B | 12.8B | Dividends Paid | 4.4B | 2.6B | 10.4M | 9.9M |
Aurobindo Pharma cash flow statement Correlations
Click cells to compare fundamentals
Aurobindo Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aurobindo Pharma cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (15.9B) | 15.0B | (9.3B) | (13.0B) | (7.4B) | (7.0B) | |
| Change In Cash | 25.8B | (11.7B) | 2.3B | (10.1B) | 21.8B | 22.9B | |
| Free Cash Flow | 14.6B | 23.1B | (3.3B) | (11.3B) | 19.6B | 20.5B | |
| Change In Working Capital | (10.7B) | 15.6B | (10.9B) | (16.8B) | (9.3B) | (8.9B) | |
| Begin Period Cash Flow | 27.5B | 53.3B | 41.6B | 43.9B | 33.9B | 35.5B | |
| Total Cashflows From Investing Activities | 6.0B | (32.1B) | (39.8B) | (45.4B) | (18.8B) | (19.7B) | |
| Other Cashflows From Financing Activities | 65.1M | (689.1M) | 22.6B | (4.0B) | (5.5B) | (5.3B) | |
| Depreciation | 10.6B | 11.3B | 12.4B | 14.9B | 16.5B | 17.3B | |
| Other Non Cash Items | (28.1B) | (10.4B) | (299.6M) | (5.6B) | (2.8B) | (2.9B) | |
| Dividends Paid | 2.3B | 2.6B | 4.4B | 2.6B | 10.4M | 9.9M | |
| Capital Expenditures | 18.7B | 27.0B | 27.2B | 35.6B | 19.7B | 12.8B | |
| Total Cash From Operating Activities | 33.3B | 50.2B | 23.9B | 24.3B | 39.2B | 41.2B | |
| Net Income | 73.4B | 33.7B | 26.1B | 31.7B | 34.9B | 21.1B | |
| Total Cash From Financing Activities | (13.6B) | (29.7B) | 18.1B | 8.0B | 1.2B | 1.3B | |
| End Period Cash Flow | 53.3B | 41.6B | 43.9B | 33.9B | 55.6B | 58.4B | |
| Other Cashflows From Investing Activities | 191.5M | 1.0B | (12.6B) | (19.3B) | 152.9M | 160.5M | |
| Change To Account Receivables | 7.4B | (4.1B) | (4.3B) | (2.6B) | (8.6B) | (8.2B) | |
| Investments | (4.9B) | (4.1B) | (39.8B) | (42.6B) | (18.8B) | (17.8B) | |
| Net Borrowings | (16.3B) | (10.8B) | (26.9B) | 23.7B | 21.3B | 22.4B | |
| Change To Operating Activities | 12.0B | (3.2B) | 3.6B | (4.4B) | (4.0B) | (3.8B) | |
| Change To Netincome | 2.6B | (19.9B) | (3.2B) | 3.1B | 2.8B | 2.9B | |
| Change To Liabilities | 3.0B | 1.3B | 1.1B | 7.1B | 8.1B | 8.5B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aurobindo Stock
The Cash Flow Statement is a financial statement that shows how changes in Aurobindo balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aurobindo's non-liquid assets can be easily converted into cash.